|
VIPAR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.529700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.63960000000496E-05 |
| Normal-vs-Stage2 |
8.369400E-01 |
| Normal-vs-Stage3 |
4.460800E-01 |
| Normal-vs-Stage4 |
6.390400E-01 |
| Stage1-vs-Stage2 |
1.545690E-02 |
| Stage1-vs-Stage3 |
2.16669999999475E-05 |
| Stage1-vs-Stage4 |
3.518400E-01 |
| Stage2-vs-Stage3 |
4.660800E-01 |
| Stage2-vs-Stage4 |
7.337800E-01 |
| Stage3-vs-Stage4 |
4.486000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.721600E-02 |
| Normal-vs-AfricanAmerican |
8.175600E-02 |
| Normal-vs-Asian |
1.093970E-01 |
| Caucasian-vs-AfricanAmerican |
5.513000E-01 |
| Caucasian-vs-Asian |
2.818600E-01 |
| AfricanAmerican-vs-Asian |
3.326400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.637800E-02 |
| Normal-vs-Female |
6.266500E-02 |
| Male-vs-Female |
7.271400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.891800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.200100E-03 |
| Normal-vs-Age(61-80Yrs) |
6.696600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.116200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.087600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.133200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.981200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.981100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.081420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.525800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.032900E-04 |
| Normal-vs-Grade 2 |
1.232280E-04 |
| Normal-vs-Grade 3 |
6.511800E-01 |
| Normal-vs-Grade 4 |
9.219800E-01 |
| Grade 1-vs-Grade 2 |
4.222600E-04 |
| Grade 1-vs-Grade 3 |
3.56209999996526E-06 |
| Grade 1-vs-Grade 4 |
1.696530E-03 |
| Grade 2-vs-Grade 3 |
8.620600E-04 |
| Grade 2-vs-Grade 4 |
1.989980E-01 |
| Grade 3-vs-Grade 4 |
8.093200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.44579999995199E-07 |
| Normal-vs-ccB subtype |
4.706000E-01 |
| ccA subtype-vs-ccB subtype |
1.15219999985428E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.334100E-02 |
| Normal-vs-N1 |
7.297400E-03 |
| N0-vs-N1 |
1.615290E-03 |
|
|
